When customers speak, Mary’s listens.

Overwhelmingly, Mary’s was hearing that there was a need for a unique and reliable vape product. Staying true to our core values, Mary’s set out to manufacture a pure, additive free, industry-leading vape pen. After a year of research into nearly every aspect of the product, from formulation to hardware, Mary’s is proud to introduce our CBD:THC 3:1 vape.

As with every Mary’s product, our research and development is rooted in a deep understanding of cannabis science coupled with invaluable feedback from our loyal customers. With the addition of this product, Mary’s customers now have access to a reliable, accurately dosed vape from the brand they have grown to trust.

With an earthy flavor and fresh aromatic scent, Mary’s new vape offers instant relaxing relief without the intense high often associated with a straight THC vape. This all-natural terpene blend is smooth with no cutting agents and includes clear, clean oil from distillate.

  • 500 mg pyrex glass cartridges
  • High Cannabinoid Potency
  • Additive Free
  • Convenient, discreet, rapid uptake
  • Accurately dosed draw count
  • Relaxing without the high

Mary’s Medicinals products are currently available in Arizona, California, Colorado, Illinois, Oregon, Nevada, Vermont and Washington. Look for Mary’s products in additional states in 2017. Where to Find Mary’s Products.

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.


Please follow and share: